These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Ketamine and other glutamate receptor modulators for depression in adults with unipolar major depressive disorder. Dean RL; Hurducas C; Hawton K; Spyridi S; Cowen PJ; Hollingsworth S; Marquardt T; Barnes A; Smith R; McShane R; Turner EH; Cipriani A Cochrane Database Syst Rev; 2021 Sep; 9(9):CD011612. PubMed ID: 34510411 [TBL] [Abstract][Full Text] [Related]
7. A Systematic Review on the Efficacy of Intravenous Racemic Ketamine for Bipolar Depression. Joseph B; Parsaik AK; Ahmed AT; Erwin PJ; Singh B J Clin Psychopharmacol; 2021 Jan/Feb 01; 41(1):71-75. PubMed ID: 33347027 [TBL] [Abstract][Full Text] [Related]
8. Neural correlates of rapid antidepressant response to ketamine in bipolar disorder. Nugent AC; Diazgranados N; Carlson PJ; Ibrahim L; Luckenbaugh DA; Brutsche N; Herscovitch P; Drevets WC; Zarate CA Bipolar Disord; 2014 Mar; 16(2):119-28. PubMed ID: 24103187 [TBL] [Abstract][Full Text] [Related]
9. [Ketamine, psilocybin, and rapid acting antidepressant: new promise for psychiatry?]. Bottemanne H; Claret A; Fossati P Encephale; 2021 Apr; 47(2):171-178. PubMed ID: 33190819 [TBL] [Abstract][Full Text] [Related]
12. A review of ketamine in affective disorders: current evidence of clinical efficacy, limitations of use and pre-clinical evidence on proposed mechanisms of action. Naughton M; Clarke G; O'Leary OF; Cryan JF; Dinan TG J Affect Disord; 2014 Mar; 156():24-35. PubMed ID: 24388038 [TBL] [Abstract][Full Text] [Related]
13. Change in cytokine levels is not associated with rapid antidepressant response to ketamine in treatment-resistant depression. Park M; Newman LE; Gold PW; Luckenbaugh DA; Yuan P; Machado-Vieira R; Zarate CA J Psychiatr Res; 2017 Jan; 84():113-118. PubMed ID: 27718369 [TBL] [Abstract][Full Text] [Related]
14. Meta-analysis of short- and mid-term efficacy of ketamine in unipolar and bipolar depression. Romeo B; Choucha W; Fossati P; Rotge JY Psychiatry Res; 2015 Dec; 230(2):682-8. PubMed ID: 26548981 [TBL] [Abstract][Full Text] [Related]
15. Efficacy of single and repeated administration of ketamine in unipolar and bipolar depression: a meta-analysis of randomized clinical trials. Kryst J; Kawalec P; Mitoraj AM; Pilc A; Lasoń W; Brzostek T Pharmacol Rep; 2020 Jun; 72(3):543-562. PubMed ID: 32301056 [TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of ketamine in bipolar depression: A systematic review. Alberich S; Martínez-Cengotitabengoa M; López P; Zorrilla I; Núñez N; Vieta E; González-Pinto A Rev Psiquiatr Salud Ment; 2017; 10(2):104-112. PubMed ID: 27387226 [TBL] [Abstract][Full Text] [Related]
17. New Developments in the Use of Atypical Antipsychotics in the Treatment of Bipolar Disorder: a Systematic Review of Recent Randomized Controlled Trials. Keramatian K; Chakrabarty T; Saraf G; Yatham LN Curr Psychiatry Rep; 2021 May; 23(7):39. PubMed ID: 33963957 [TBL] [Abstract][Full Text] [Related]
18. Rethinking ketamine and esketamine action: Are they antidepressants with mood-stabilizing properties? d'Andrea G; Pettorruso M; Lorenzo GD; Mancusi G; McIntyre RS; Martinotti G Eur Neuropsychopharmacol; 2023 May; 70():49-55. PubMed ID: 36867895 [TBL] [Abstract][Full Text] [Related]
19. KETAMINE FOR TREATMENT-RESISTANT UNIPOLAR AND BIPOLAR MAJOR DEPRESSION: CRITICAL REVIEW AND IMPLICATIONS FOR CLINICAL PRACTICE. Bobo WV; Vande Voort JL; Croarkin PE; Leung JG; Tye SJ; Frye MA Depress Anxiety; 2016 Aug; 33(8):698-710. PubMed ID: 27062450 [TBL] [Abstract][Full Text] [Related]
20. Antiviral treatment perspective against Borna disease virus 1 infection in major depression: a double-blind placebo-controlled randomized clinical trial. Dietrich DE; Bode L; Spannhuth CW; Hecker H; Ludwig H; Emrich HM BMC Pharmacol Toxicol; 2020 Feb; 21(1):12. PubMed ID: 32066504 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]